To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.

Velocity Clinical Research, an integrated research site organization, has appointed Ines Abs as its new Country Head of ...

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

Dr. Keith Robinson joins as Chief Medical Officer and Dr. Lonnie Brent has been appointed Senior Vice President of Medical ...

Flow Sciences, a global leader in advanced containment solutions, announced the opening of a new office in the Research ...

Symbiosis Pharmaceutical Services, a global CMO, has successfully completed its 1,000th sterile drug product batch. The ...

The new 1,200 square-meter facility in Germany expands headquarters to support growth and scale Human Platelet Lysate ...

Evotec SE has signed a non-binding agreement with Sandoz AG regarding the potential sale of Just – Evotec Biologics EU, which ...

This acquisition strengthens Tobin Scientific's regional footprint in New England as well as its life sciences capabilities.

This platform aims to deliver high-quality cyclic peptides with faster timelines and better economy across a broad range of ...

Novo Nordisk has appointed Maziar Mike Doustdar as President and CEO, effective August 7, 2025. Doustdar succeeds Lars ...